Liu, X;
Cruz Rivera, S;
Moher, D;
Calvert, MJ;
Denniston, AK;
Ashrafian, H;
Beam, AL;
... Yau, C; + view all
(2020)
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
The Lancet Digital Health
, 2
(10)
e537-e548.
10.1016/S2589-7500(20)30218-1.
Preview |
Text
1-s2.0-S2589750020302181-main.pdf - Published Version Download (497kB) | Preview |
Abstract
The CONSORT 2010 statement provides minimum guidelines for reporting randomised trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders), and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human–AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret, and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.
| Type: | Article |
|---|---|
| Title: | Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S2589-7500(20)30218-1 |
| Publisher version: | http://dx.doi.org/10.1016/S2589-7500(20)30218-1 |
| Language: | English |
| Additional information: | © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10111082 |
Archive Staff Only
 |
View Item |
